SAN FRANCISCO – Looking back on what he called the "golden era" of private equity funding that ran from about 2004 to 2007, Larry Alletto, global head of the financial sponsor group at J.P. Morgan, and panel moderator for a discussion on that sector at this year's healthcare meeting, recalled a time that was characterized by ever larger deals fueled by cheap money and the ability to acquire very large market leading businesses that would have normally been off limits to that type of funding. (Medical Device Daily) Read More
